drugset / Trial / NCT02056340
Statin Therapy in Acute Influenza
Phase 2
Completed
116 enrolled
Beth Israel Deaconess Medical Center
National Institute of General Medical Sciences (NIGMS) · collab
RandomizedParallel-groupTriple-blindTreatment
Summary
Influenza (the 'flu') is a common virus infecting approximately 5-20% of the population in the United States and causing as many as 500,000 deaths worldwide each year. Currently, there are only a few treatments for influenza infection and none of these target inflammation that can be caused by the virus. This study will test whether the anti-inflammatory effects of statins, a class of drugs most often used to treat high cholesterol, will decrease the severity of illness in patients who are infected with influenza by testing markers of inflammation in the blood and recording resolution of influenza illness.
Timeline
- Start
- 2013-10
- Primary completion
- 2018-06-30
- Completion
- 2018-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Atorvastatin | Small molecule | 40 mg | Oral |